Andrew C. Jackson
Chief Financial Officer · Calidi Biotherapeutics, Inc.
- 2025
- Aug 19, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew C. Jackson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Allan Camaisa - $1K in CLDI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew C. Jackson?
Andrew C. Jackson is a corporate insider, tracked as Chief Financial Officer of Calidi Biotherapeutics, Inc. (CLDI). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew C. Jackson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Andrew C. Jackson been buying or selling stock?
Recorded transactions: 2 open-market purchases ($5K) and 0 open-market sales across all tracked filings.
